Evaluation of the effectiveness of additional risk minimisation measures (aRMMs) that aim to reduce the risks of phototoxicity, squamous cell carcinoma (SCC) of the skin and hepatic toxicity in patients receiving voriconazole in Saudi Arabia

First published 30/10/2024

Last updated 30/10/2025

EU PAS number:

EUPAS1000000266

Study

Finalised

Documents

Study protocol

Initial protocol

A1501110_Non Interventional Study Protocol (Combined)_V1_16AUG2024_Redacted.pdf

English (558.23 KB - PDF) View document

Study results

Study report

A1501110_Non-Interventional Study Report_V1_20JUN2025_Redacted.pdf

English (627.65 KB - PDF) View document

Other information

Study, other information

A1501110_Non-Interventional Study Report_V2_03OCT2025_Redacted.pdf

English (376.25 KB - PDF) View document

Secondary tabs